Media - Bakgrunn
The Mölnlycke Wound Care division develops and manufactures dressings designed specifically for chronic and surgical wounds, such as venous leg ulcers, pressure ulcers or burns. The assortment also comprises complementary products within compression therapy and dermatology.
The wound care market dynamic is driven by the aging population. This implies higher incidence of many chronic and acute wounds. Mölnlycke Health Care is the global market leader within wound care dressings. Advanced dressings with Safetac® technology is becoming a first choice for an increasing number of care givers worldwide. The R&D department of Mölnlycke constantly develops dressings to increase their efficacy – with a number of new products in pipe-line.
The advanced dressings market is valued at approx 2.3 billion euro and it’s growing at around 4% yearly. A big part of this change from conventional to advanced wound dressings can be attributed to the growth of the Mölnlycke Health Care dressings with Safetac.